Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
CymaBay Therapeutics Inc (NASDAQ: CBAY) Announces Promising Seladelpar Data In Treatment…
Chimerix Inc (NASDAQ: CMRX) Receives $25.3 Million Procurement Contract For TEMBEXA
Regulus Therapeutics Inc (NASDAQ: RGLS) Pleased after FDA Approved its Orphan…
Ocugen Inc (NASDAQ: OCGN) Announces the Successful Publication of Positive Outcomes…
Brickell Biotech Inc (NASDAQ: BBI) Announces Dosing of First Subject with…
Finance
Why Your Body Needs Nitric Oxide Boost Beets For More Energy…
Top Beer Stocks for the Recession-Proof Portfolio (BUD, KEGS, SAM, TAP,…
Cutting Edge Power announces an all-new version of its popular Smart…
Lucid Group Inc (NASDAQ:LCID) Poised for Action as New Catalysts Mount
Galera Therapeutics Inc. (NASDAQ: GRTX) Announced Updated Findings Of Phase 3…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Finance
Finance
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Why Your Body Needs Nitric Oxide Boost Beets For More Energy And Stamina
Ward Sport
-
June 28, 2022
Top Beer Stocks for the Recession-Proof Portfolio (BUD, KEGS, SAM, TAP, STZ, DEO, ABEV, HEINY)
Cutting Edge Power announces an all-new version of its popular Smart Tech Power Meter
Lucid Group Inc (NASDAQ:LCID) Poised for Action as New Catalysts Mount
Galera Therapeutics Inc. (NASDAQ: GRTX) Announced Updated Findings Of Phase 3 ROMAN Study of Evasopasem in TY-induced SOM
Pasithea Therapeutics Corp (NASDAQ: KTTA) Expands IV Ketamine Therapy Availability In...
Kate Hudson
-
December 20, 2021
0
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) Doses Subjects In Study Evaluating selinexor...
Gavins Felicity
-
December 15, 2021
0
Ionis Pharmaceuticals Inc. (NASDAQ: IONS) Announce Update Regarding Vupanorsen Study In...
Matt Wade
-
December 8, 2021
0
Inhibikase Therapeutics Inc. (NASDAQ: IKT) Publishes Study Showing Oral c-Abl Kinase...
Gavins Felicity
-
December 7, 2021
0
Time to Revisit Previously Booming CBD Space for Big Growth on...
Matt Wade
-
December 3, 2021
0
Bitcoin Stocks Primed as Inflation Concerns Build (BKKT, ISWH, RIOT, MARA,...
Kate Hudson
-
December 3, 2021
0
Top Clean Energy Stocks are On Sale and Structurally Favored (CLNE,...
Gavins Felicity
-
December 3, 2021
0
Timber Pharmaceuticals Inc. (NYSEAMERICAN: TMBR) Reports Results From TMB-001 Study And...
Gavins Felicity
-
December 3, 2021
0
Biotech Growth Stocks Set to Benefit from Rising Volatility (REGN, OTLC,...
Ash K
-
December 2, 2021
0
Spotlight on Top Stocks in the Growing Sports Nutrition Space (USNA,...
Matt Wade
-
December 2, 2021
0
1
2
3
...
13
Page 1 of 13
Recent Post
CymaBay Therapeutics Inc (NASDAQ: CBAY) Announces Promising Seladelpar Data In Treatment...
Gavins Felicity
-
July 5, 2022
0
CymaBay Therapeutics Inc (NASDAQ: CBAY) has announced the presentation of promising seladelpar findings in primary biliary cholangitis (PBC) patients at The International Liver Congress...
Chimerix Inc (NASDAQ: CMRX) Receives $25.3 Million Procurement Contract For TEMBEXA
July 4, 2022
Regulus Therapeutics Inc (NASDAQ: RGLS) Pleased after FDA Approved its Orphan...
July 1, 2022
Cannabis Stocks Deeply Oversold with Big Growth Ahead (TLRY, SGMD, OGI,...
June 30, 2022
Ocugen Inc (NASDAQ: OCGN) Announces the Successful Publication of Positive Outcomes...
June 30, 2022